Bookmark and Share

Compound Summary for: CID 148189

irofulven

Also known as: HMAF, MGI 114, 6-(Hydroxymethyl)acylfulvene, MGI-114, NSC 683863, Acylfulvene, 6-(hydroxymethyl)-, 158440-71-2
Molecular Formula: C15H18O3   Molecular Weight: 246.30162   InChIKey: NICJCIQSJJKZAH-AWEZNQCLSA-N
A novel anti-cancer compound synthesized by scientists at the University of California, San Diego more than a decade ago from toxins of the poisonous jack-o-lantern mushroom, has been granted ??fast track? status by the U.S. Food and Drug Administration (FDA) after demonstrating promise against one of the most deadly cancers. MGI-114 (Irofulven) is currently being developed by MGI PHARMA, Inc., an emerging oncology-focused pharmaceutical company based in Minneapolis. Phase III clinical trials involving the drug have been underway since early 2001 at sites in the U.S. and Europe.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _